美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ready Capital Corp

25.04

0.0000

成交量：- -

成交額：- -

市值：41.15億

市盈率：-12.77

高：25.04

開：25.04

低：25.04

收：25.04

52周最高：26.87

52周最低：23.97

股本：1.64億

流通股本：1.64億

量比：- -

換手率：- -

股息：1.44

股息率：5.74%

每股收益(TTM):-1.9610

淨資產收益率：-13.30%

總資產收益率：-2.87%

市淨率：2.47

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Trevi Therapeutics完成1.73億美元承銷發行承銷商全額行使超額配售權

Trevi Therapeutics宣佈擬進行普通股公開發行

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/RCC"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RCC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RCC\",,,,,undefined,":{"symbol":"RCC","market":"US","secType":"STK","nameCN":"Ready Capital Corp","latestPrice":25.04,"timestamp":1783627200000,"preClose":25.04,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":164327000,"shares":164327000,"eps":-1.961,"marketStatus":"未開盤","change":0,"latestTime":"07-09 16:00:00 EDT","open":25.04,"high":25.04,"low":25.04,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.961,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"exchange":"NYSE","adjPreClose":25.04,"dividendRate":0.05741,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RCC\",,,,,undefined,":{"symbol":"RCC","floatShares":164327000,"roa":"-2.87%","roe":"-13.30%","lyrEps":0,"shares":164327000,"dividePrice":1.437535,"high":25.04,"amplitude":0,"preClose":25.04,"low":25.04,"week52Low":23.97,"pbRate":"2.47","psRate":"-38.40","week52High":26.87,"institutionHeld":0,"latestPrice":25.04,"eps":-1.961,"divideRate":0.05741,"volume":0,"delay":0,"ttmEps":-1.961,"open":25.04,"prevYearClose":25.05,"prevWeekClose":25.04,"prevMonthClose":24.92,"prevQuarterClose":25.05},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RCC\",params:#limit:5,,,undefined,":[{"date":"2026-02-26","symbol":"RCC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772139600000,"name":null,"time":"盤後","dateTimestamp":1772082000000,"actualEps":null},{"market":"US","date":"2026-02-17","symbol":"RCC","reason":null,"defaultRemindTime":1771338600000,"announcedDate":"2026-01-26","type":"delisting","dateTimestamp":1771304400000},{"date":"2026-01-15","symbol":"RCC","amount":0.3594,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-15","defaultRemindTime":1768487400000,"name":"Ready Capital Corp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-30","payableDate":"2026-01-15","currency":"USD","dateTimestamp":1768453200000,"payDate":"2026-01-30"},{"date":"2025-10-15","symbol":"RCC","amount":0.359375,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-15","defaultRemindTime":1760535000000,"name":"Ready Capital Corp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-30","payableDate":"2025-10-15","currency":"USD","dateTimestamp":1760500800000,"payDate":"2025-10-30"},{"date":"2025-07-15","symbol":"RCC","amount":0.35938,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-15","defaultRemindTime":1752586200000,"name":"Ready Capital Corp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-30","payableDate":"2025-07-15","currency":"USD","dateTimestamp":1752552000000,"payDate":"2025-07-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RCC\",market:\"US\",,,undefined,":[{"executeDate":"2021-04-14","recordDate":"2021-04-15","paymentDate":"2021-04-30","value":0.3194444,"currency":"USD"},{"executeDate":"2021-07-14","recordDate":"2021-07-15","paymentDate":"2021-07-30","value":0.359375,"currency":"USD"},{"executeDate":"2021-10-14","recordDate":"2021-10-15","paymentDate":"2021-10-30","value":0.359375,"currency":"USD"},{"executeDate":"2022-01-13","recordDate":"2022-01-14","paymentDate":"2022-01-30","value":0.359375,"currency":"USD"},{"executeDate":"2022-04-13","recordDate":"2022-04-14","paymentDate":"2022-04-30","value":0.359375,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RCC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0.875,"sell":0.125,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.875,"analysts":8,"updateTime":1766120400000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RCC\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1115266921","title":"Trevi Therapeutics完成1.73億美元承銷發行 承銷商全額行使超額配售權","url":"https://stock-news.laohu8.com/highlight/detail?id=1115266921","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115266921?lang=zh_tw&edition=fundamental","pubTime":"2026-04-21 04:08","pubTimestamp":1776715692,"startTime":"0","endTime":"0","summary":"临床阶段生物制药公司Trevi Therapeutics近日宣布，其此前公布的承销公开发行已正式完成。本次发行以每股13.00美元的价格公开发行13,340,000股普通股，其中包括承销商全额行使期权，以发行价额外购买的1,740,000股普通股。在扣除承销折扣和佣金前，本次发行总收益约为1.73亿美元。所有发行股份均由Trevi公司售出。Trevi拟将Haduvio作为口服纳布啡缓释片的商品名。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0528227936.USD","LU0234570918.USD","BK4585","LU0098860793.USD","MS","LU2023251221.USD","LU0158827948.USD","BK4539","LU0971096721.USD","LU2347655156.SGD","LU0106261372.USD","LU1791710582.SGD","BK4099","LU2111349929.HKD","LU1244550577.SGD","LU1363072403.SGD","03160","LU0557290698.USD","LU0158827781.USD","LU2133065610.SGD","LU1548497426.USD","LU1791710400.SGD","LU0320765646.SGD","LU0795875086.SGD","LU2028103732.USD","LU2089284900.SGD","LU1244550221.USD","LU1989772923.USD","LU0106831901.USD","LU1074936037.SGD","LENZ","IE00BKVL7J92.USD","LU1989772840.SGD","LU0314104364.USD","BK4534","LU2271345857.HKD","BK4504","LU2357305700.SGD","LU1244550494.USD","LU0795875169.SGD","LU0225283273.USD","BK4127","BK4588","LU2089283258.USD","BK4555","RCC","BK4516","LU1732800096.USD","TM","LU0267386448.USD","LU1732799900.SGD","BK4581","BK4604","TRVI","IE00BZ1G4Q59.USD","LU0006306889.USD","BK4139","BK4007","LU0912757837.SGD","LU1162221912.USD","LU1720051017.SGD","LU0882574139.USD","LU1720051108.HKD","LU1668664300.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138495751","title":"Trevi Therapeutics宣佈擬進行普通股公開發行","url":"https://stock-news.laohu8.com/highlight/detail?id=1138495751","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138495751?lang=zh_tw&edition=fundamental","pubTime":"2026-04-17 04:11","pubTimestamp":1776370286,"startTime":"0","endTime":"0","summary":"临床阶段生物制药公司Trevi Therapeutics今日宣布，已启动承销式公开发行，计划发售总值1.5亿美元的普通股。本次发行全部股份均由Trevi提供。公司还拟授予承销商30天超额配售选择权，可额外认购最多2250万美元的普通股，发行价格将扣除承销折扣与佣金。摩根士丹利、Leerink Partners、Cantor及Stifel担任此次发行的联席账簿管理人，Oppenheimer & Co.则出任牵头经理。Trevi计划将Haduvio作为口服纳布啡缓释片的商品名，其安全性与有效性尚未获得任何监管机构评估。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732799900.SGD","LU2357305700.SGD","BK4534","LU2111349929.HKD","LU1791710582.SGD","BK4139","LU0158827781.USD","LU1989772923.USD","LU0320765646.SGD","LU1244550221.USD","BK4127","BK4585","LU0006306889.USD","LU0314104364.USD","RCC","LU2271345857.HKD","03160","LU0267386448.USD","LU1548497426.USD","LU0225283273.USD","LU0158827948.USD","LU2133065610.SGD","BK4555","LU2089283258.USD","LU0795875169.SGD","BK4007","IE00BKVL7J92.USD","LU0098860793.USD","LU0557290698.USD","LU0912757837.SGD","LU1074936037.SGD","LU1363072403.SGD","LU1720051108.HKD","LU2347655156.SGD","MS","BK4099","LU2023251221.USD","LU0795875086.SGD","TM","LU1732800096.USD","TRVI","LU1720051017.SGD","BK4581","IE00BZ1G4Q59.USD","LU0528227936.USD","LU1244550494.USD","BK4516","LU2028103732.USD","LU1791710400.SGD","LU1668664300.SGD","LU1989772840.SGD","LU0106261372.USD","BK4588","LU1162221912.USD","LENZ","LU0234570918.USD","LU0971096721.USD","BK4539","LU2089284900.SGD","LU0106831901.USD","BK4604","LU0882574139.USD","LU1244550577.SGD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RCC\",params:#limit:6,delay:false,,,undefined,":[]}}